🔗 Share this article

Treasury head Rachel Reeves has announced she is preparing "specific measures to deal with cost of living issues" in next month's Budget.

In comments to media outlets, she emphasized that curbing price rises is a shared duty of both the government and the Bank of England.

The United Kingdom's price growth is projected to be the highest among the Group of Seven developed nations this calendar year and the following year.

Potential Utility Cost Measures

Reports indicate the government could intervene to reduce utility costs, for instance by cutting the current 5% level of value-added tax charged on energy.

A further option is to reduce some of the government charges presently included in household expenses.

Fiscal Limitations and Analyst Predictions

The administration will receive the latest assessment from the independent fiscal watchdog, the Office for Budget Responsibility, on the start of the week, which will reveal how much room there is for such measures.

The expectation from the majority of analysts is that Reeves will have to announce tax rises or expenditure reductions in order to meet her self-imposed debt limits.

Earlier on Thursday, calculations showed there was a twenty-two billion pound deficit for the Treasury chief to fill, which is at the more modest range of projections.

"There's a shared job between the central bank and the government to continue tackling some of the sources of inflation," the Chancellor stated to reporters in Washington, at the annual meetings of the IMF and global financial institution.

Tax Pledges and Global Issues

While a great deal of the focus has been on probable tax rises, the Treasury chief said the most recent figures from the OBR had not changed her commitment to manifesto promises not to increase tax levels on income tax, sales tax or National Insurance.

She attributed an "unpredictable global environment" with increasing geopolitical and trade concerns for the Budget revenue measures, probably to be focused on those "wealthiest."

International Trade Disputes

Addressing apprehensions about the United Kingdom's trade ties with China she said: "The UK's security interests always come first."

Last week's statement by China to tighten trade restrictions on rare earths and other materials that are essential for high-technology manufacturing led US President the US President to suggest an extra 100% import tax on imports from China, raising the prospect of an full-scale commercial conflict between the two global powers.

The American finance chief labeled the Chinese move "economic coercion" and "a global supply chain power grab."

Asked about considering the American proposal to participate in its battle with the Asian nation, Reeves said she was "deeply worried" by China's actions and urged the Beijing authorities "not to put up barriers and restrict access."

She said the decision was "harmful for the world economy and creates additional headwinds."

"In my view there are areas where we should confront Chinese policies, but there are also significant chances to trade with China's economy, including banking sector and other areas of the economic system. We've got to achieve that balance correct."

The chancellor also affirmed she was working with other major economies "on our own critical minerals strategy, so that we are more independent."

Health Service Medicine Costs and Funding

The Chancellor also recognized that the cost the National Health Service pays for drugs could increase as a result of current talks with the Trump administration and its pharmaceutical firms, in return for reduced taxes and capital.

A number of the world's largest pharmaceutical manufacturers have said in recent statements that they are either halting or abandoning projects in the UK, with some blaming the modest returns they are obtaining.

Recently, the government science advisor said the cost the health service pays for drugs would need to increase to stop firms and drug research funding departing from the United Kingdom.

The Chancellor told media: "It has been observed because of the payment system, that clinical trials, new drugs have not been provided in the UK in the extent that they are in other EU nations."

"Our aim is to make sure that patients receiving care from the National Health Service are can receive the finest life-saving drugs in the globe. And so we are examining all of that, and... seeking to obtain increased investment into Britain."